Strama
Welcome to Strama - the Swedish strategic programme against antibiotic resistance.
SWEDRES 2010
A Report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine, published by Strama and The Swedish Institute for Infectious Disease Control. Announced June 9th 2011.
The majority of Swedish population is willing to abstain from antibiotics
The results from an interview study called the Health Barometer 2010 shows that 78% of the Swedish population is willing to abstain from antibiotics even if they risk a few additional days of morbidity. The proportion willing to abstain from antibiotics varies between counties, from 84% in Uppsala to 73% in Göteborg.Click here to read the report (In Swedish)
Click here for link to the home page

Sweden Sets National Target for Antibiotic Use in Outpatient Care
In December 2010 the Swedish Government announced a 500 million SEK commitment to improving patient safety in health care during 2011 out of which 100 million SEK will be allocated to the work with improving rational use of antibiotics. In 2010 the average use of antibiotics in outpatient care* in Sweden was 390 prescriptions per 1000 inhabitants. There are however, great regional differences.The 100 million SEK to be shared between the 21 county councils in Sweden are conditional in the way that for county councils to receive any funding they are firstly required to form a Strama group with a clear mandate to coordinate local activities. Secondly, prescribers must increase the adherence to treatment recommendations aiming at no more than 250 prescriptions per 1000 inhabitants per year by 2014, a national target set by the Swedish government. The funding will be allocated yearly in relation to potential step-wise fulfillment of the mentioned criteria.
* Outpatient care refers to antibiotics prescribed in primary care and open specialist surgeries.
New organisation of Strama
From July 1st 2010, Strama (the Swedish Strategic Programme against Antibiotic Resistance) is an advisory body with the remit to assist the Swedish Institute for Infectious Disease Control in:1) matters regarding antibiotic use and containment of antibiotic resistance
2) facilitating an interdisciplinary and locally approved working model, ensuring involvement by concerned authorities, counties, municipalities and non-profit organizations.
Council Conclusions on innovative incentives for effective Antibiotics
At the EU Minister of Health meeting on 1 December the Council adopted conclusions as a result of the conference " Innovative Incentives for Effective Antibacterials"EU-US summit agrees to form transatlantic taskforce on antimicrobial resistance
At the EU-US Summit on the 3rd of November, it was agreed to establish a transatlantic taskforce on urgent antimicrobial resistance issues.
Conference Innovative Incentives for Effective Antibacterials
The Presidency hosted an expert conference about the antibiotic resistance threat on 17 September in Stockholm.
China and Sweden in collaboration against antibiotic resistance
Read more and watch pictures from the meeting in Beijing on April 28.
Fact Sheets on the Burden of Antibiotic Resistance
The Burden of Antibiotic Resistance in several areasof healthcare is discussed in fact sheets published by ReAct, the worldwide network for action on antibiotic resistance.
European recommendations on healthcare associated infections
The Commission has adopted a proposal for Council recommendations on patient safety. Healthcare associated infections are mentioned as an example of preventable injuries. Systematic efforts including education and improved reporting are methods that have proven efficient.The proposal and other documents can be found at the Commission´s homepage.
We are facing a global pandemic of antibiotic resistance, warn experts
Vital components of modern medicine such as major surgery, organ transplantation, and cancer chemotherapy will be threatened if antibiotic resistance is not tackled urgently, warn experts on bmj.com today.
Sweden has the lowest use of antibiotics in the Nordic countries, but the use of quinolones is still high
Click on "Read more" for statistics!
10-year follow-up of the Swedish Strama programme
In the February issue of The Lancet Infectious Diseases a 10-year follow-up of the Swedish Strama programme is described.











På svenska